Divergent and convergentevolution in metastasessuggest treatment strategies based onspecific metastatic sites

Evolution, Medicine and Public Health

Volumn 2015, Issue 1, 2015, Pages 76-87

  Cunningham, Jessica J ^a   Brown, Joel S ^b   Vincent, Thomas L ^c   Gatenby, Robert A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c University of Arizona   (United States)

Author keywords

Cancer therapy; Evolution; Evolutionary game theory; Metastases

Indexed keywords

ARTICLE; CANCER TISSUE; CONVERGENT EVOLUTION; DISSEMINATED CANCER; EPITHELIUM CELL; HUMAN; LIVER METASTASIS; MATHEMATICAL MODEL; MESENCHYME CELL; METASTASIS; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR MICROENVIRONMENT;

EID: 84995361260     PISSN: None     EISSN: 20506201     Source Type: Journal    
DOI: 10.1093/emph/eov006     Document Type: Article

References (42)

1. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-58.
2. Chambers AF, Groom AC, MacDonald IC. Metastasis: dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
3. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4:448-56.
4. Wyckoff JB, Jones JG, Sondeelis JS et al. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 2000;60:2504-11.
5. Luzzi KJ, MacDonald IC, Schmidt EE et al. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Path 1988;153:865-73
6. Weiss L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 1992;10:191-9.
7. Naumov GN, MacDonald IC, Weinmeister PM et al. Persistence of solitary mammary carcinoma cells in a secondary site a possible contributor to dormancy. Cancer Res 2000;62:2162-8.
8. Fidler IJ, Nicolson GL. Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients. J Natl Cancer Inst 1977;58:1867-72.
9. McGowan PM, Kirstein JM, Chambers AF. Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches. Future Oncol 2009; 5:1083-98.
10. Cameron MD, Schmidt EE, Kerkvliet N et al. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 2000;60:25410-6.
11. Liotta LA, Vembu D, Saini RK et al. In vivo monitoring of the death rate of artificial murine pulmonary micrometastases. Cancer Res 1978;38:1231-6.
12. Riethdorf S, Wikman H, Pantel K. Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer 2008;123:1991-2006.
13. Powell S, Dudek AZ. Single-institution outcome of highdose Interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases. Anticancer Res 2009;29:4189-94.
14. Roubaud G, Gross-Goupil M, Wallerand H et al. Combination of gemcitabine and doxorubicin in rapidly progressive metastatic renal cell carcinoma and/or sarcomatoid renal cell carcinoma. Oncology 2011;80: 214-18.
15. Carretero R, Wang E, Rodriguez AI et al. Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferonmediated rejection genes. Int. J Cancer 2011;10. 1002/ ijc.26471.
16. Liern GS, Verweii J. Mixed response to chemotherapy, a new entity in soft tissue sarcomas. Eur J Cancer 1995;31: 2113-14.
17. Chua S, Tam H, Koh D-M, Cook G. The outcome and significance of mixed metabolic treatment response (MR) on interim 18F-FDG PET/CT in patients with advanced solid tumours treated with novel drugs. J Nucl Med 2010;51: 1280.
18. Kurland BF, Peterson LM, Lee JH et al. Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET. J Nucl Med 2011;52:1541-9.
19. Gottlieb RH, Krupinski E, Chalasani P et al. Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography: improving on the current standard. J Digit Imaging 2011;25: 258-65.
20. Brown JS, Vincent TL. Organization of predator-prey communities as an evolutionary game. Evolution 1992; 46:1269-83.
21. Vincent TL, Brown JS. Evolutionary Game Theory, Natural Selection and Darwinian Dynamics. Cambridge: Cambridge University Press, 2005.
22. Vincent TL, Gatenby RA. An evolutionary model for initiation, promotion, and progression in carcinogenesis. Int J Oncol 2008;32:729-37.
23. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
24. Radinsky R, Ellis LM. Molecular determinants in the biology of liver metastases. Surg Oncol Clin N Am 1999;5: 215-29.
25. Kuo TH, Kubota T, Watanabe M et al. Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci USA 1985;92:12085-99.
26. Yoneda T, Williams PJ, Hiraga T et al. A bone-seeking clone exhibits different biological properties from the MDA-MB- 231 parental human breast cancer cells and a brain seeking clone in vivo and in vitro. J Bone Miner Res 2001; 16:1486-95.
27. Zetter BR. The cellular basis of site specific tumor metastasis. N Engl J Med 1990;322:605-12.
28. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
29. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000;6:324-9.
30. Norton L, Massague J. Is cancer a disease of self-seeding? Nat Med 2006;12:875-8.
31. Rastelli F, Crispino S. Factors predictive of response to hormone therapy in breast cancer. Tumori 2008;94: 370-83.
32. Gloyeske NC, Dabb s DJ, Bhargava R. Low ER+ breast cancer: is this a distinct group? Am J Clin Pathol 2014; 141:697-701.
33. Prentis PJ, Wilson JR, Dormontt EE et al. Adaptive evolution in invasive species. Trends Plant Sci 2008;13:288-94.
34. Facon B, Pointier J-P, Jarne P et al. High genetic variance in life-history strategies within invasive populations by way of multiple introductions. Curr Biol 2008;18:363-7.
35. Buswell JM, Angela T, Moles AT et al. Is rapid evolution common in introduced plant species? J Ecol 2011;99: 214-24.
36. Yachida S, Jones S, Bozic I et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:1114-17.
37. Park ES, Kim SJ, Kim SW et al. Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis. Proc Natl Acad Sci USA 2011;108:17456-61.
38. Chen J, Lee HJ, Wu X et al. Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. Cancer Res 2014.
39. Kang Y, Siegel PM, Shu W et al. A multigenic program mediating breast cancer metastasis. Cancer Cell 2003;3: 537-49.
40. Tímár J, Gyorffy B, Rásó E. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little? Clin Exp Metastasis 2010;27:371-87.
41. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nature Rev Cancer 2005;5: 591-602.
42. Gupata GP, Minn AJ, Kang Y, Siegel PM et al. Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol 2005;9:149-58.